查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497601

血液檢測市場：按產品、檢測類型、應用和最終用戶 - 2024-2030 年全球預測

Blood Testing Market by Product (Instruments, Reagents & kits, Software), Test Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血液檢測市場規模為1,000.2億美元，2024年達1,060.1億美元，預計2030年將達1,553.1億美元，複合年成長率為6.48%。

血液檢查是一種臨床程序，在實驗室中分析血液樣本，以評估整體健康狀況、檢測病毒或細菌感染、確定各種器官的功能以及篩檢遺傳狀況。血液檢測是預防保健和醫學診斷的重要工具，並包含早期發現和早期管理疾病的寶貴資料。血液檢測應用於各醫學領域。代謝功能的常規檢測、感染疾病的增加以及對血液檢測設施的持續投資正在推動對先進血液檢測解決方案的需求。然而，嚴格的核准監管要求以及與先進測試技術相關的高成本可能會限制該產品的全球普及。此外，缺乏訓練有素的專業人員來執行和解釋複雜的血液檢查可能會限制血液檢測解決方案的使用。也就是說，測試技術的改進提供了更快、更準確、侵入性更小的測試，以及醫療基礎設施和診斷支出的增加，預計將為血液檢測市場在未來幾年提供成長機會。

主要市場統計
基準年[2023] 1000.2億美元
預測年份 [2024] 1060.1億美元
預測年份 [2030] 1553.1億美元
複合年成長率（%） 6.48%

區域洞察

美洲血液檢測市場高度新興，其特點是先進的醫療保健系統和消費者對健康狀況的高度認知。慢性病的增加、人口老化以及大型醫療保健公司的出現正在推動對血液檢測等診斷服務的需求。在歐盟 (EU) 國家，由於高醫療標準和國家醫療保健系統的存在，對血液檢查的需求很高。人們對預防性醫療保健的興趣日益濃厚，以及人口老化中慢性病的流行，正在推動市場的發展。此外，歐盟嚴格的法律規範確保了高品質的血液檢測程序和設備標準。儘管中東地區由於衛生基礎設施投資而正在經歷快速發展，但非洲許多地區卻面臨血液檢測產品的取得和負擔能力等挑戰。由於人口眾多、醫療成本上升和快速都市化，亞太地區的血液檢測市場正在快速成長。消費者友善血液檢測產品的持續創新和市場開拓預計將推動亞太地區血液檢測市場的發展。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在血液檢測市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血液檢測市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該細分市場競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在血液檢測市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行概述

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個體自體免疫疾病的盛行率以及加強護理的需要
      • 政府推出驗血健康檢查宣傳活動
      • 世界各地血液檢測設施的顯著擴張
    • 抑制因素
      • 原料成本波動與產品召回問題
    • 機會
      • 居家醫療和遠端醫療的快速採用
      • 血液檢測產品的進展
    • 任務
      • 與血液檢測產品相關的皮膚穿刺不準確和安全問題
  • 市場區隔分析
    • 類型：血液檢查中基本代謝組的顯著滲透
    • 應用：增加血液檢測套組在診斷自體免疫疾病的使用
    • 最終用戶：血液檢測產品在居家照護環境中的普及取得進展
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章血液檢測市場：依產品

  • 介紹
  • 裝置
  • 試劑和套件
  • 軟體

第7章血液檢測市場：依測試類型

  • 介紹
  • 基礎代謝組
  • 全血球計數測試
  • 完整代謝組
  • 電解質板

第8章血液檢測市場：依應用分類

  • 介紹
  • 過敏
  • 自體免疫疾病
  • 癌症/非癌症血液疾病
  • 內分泌系統疾病
  • 心臟疾病

第9章血液檢測市場：依最終用戶分類

  • 介紹
  • 血庫
  • 診斷中心
  • 醫院/診所
  • 病理實驗室

第10章美洲血液檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太血液檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的血液檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Quest Diagnostics 宣布推出 P-Tau217 血液生物標記物，用於阿茲海默症風險評估和診斷支持
    • 巴布森診斷公司推出創新的零售血液檢測服務
    • 日本衛材透過對 C2N Diagnostics 的策略性投資加強阿茲海默症檢測
  • 戰略分析和建議

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-144C638C91DF

[199 Pages Report] The Blood Testing Market size was estimated at USD 100.02 billion in 2023 and expected to reach USD 106.01 billion in 2024, at a CAGR 6.48% to reach USD 155.31 billion by 2030.

Blood testing is a clinical procedure that involves analyzing a blood sample in a laboratory to assess the general state of health, detect the presence of viral or bacterial infections, determine the functioning of various organs, and screen for genetic conditions. Blood tests are critical tools for preventive medicine and medical diagnostics, providing valuable data for early disease detection and management. Blood tests have various applications in various medical and healthcare domains. Routine testing for metabolic functions, increasing prevalence of infectious disease, and ongoing investments in blood testing facilities have enhanced the need for advanced blood testing solutions. However, strict regulatory requirements for approval and high costs associated with advanced testing technologies may restrict product penetration worldwide. In addition, a lack of trained professionals to conduct and interpret complex blood tests may limit the use of blood testing solutions. Nevertheless, the improved testing technologies that provide quicker, more accurate, and less invasive testing and Increased spending on healthcare infrastructure and diagnostics are expected to create growth opportunities for the blood testing market in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 100.02 billion
Estimated Year [2024] USD 106.01 billion
Forecast Year [2030] USD 155.31 billion
CAGR (%) 6.48%

Regional Insights

The blood testing market in the Americas is highly developing and characterized by advanced healthcare systems and higher consumer awareness of health conditions. A growing prevalence of chronic diseases, an aging population, and the presence of major healthcare companies elevate the need for diagnostic services such as blood testing. European Union (EU) countries exhibit a strong need for blood testing due to the high healthcare standards and the presence of national healthcare systems. An increasing focus on preventive care and the prevalence of chronic diseases among aging populations drives the market. Furthermore, the EU's stringent regulatory framework ensures high-quality blood testing procedures and equipment standards. The Middle East showcases rapid advancement due to investments in healthcare infrastructure, while many African regions face challenges, including accessibility and affordability of blood testing products. The Asia Pacific region represents a rapidly growing blood testing market due to large population bases, increasing healthcare expenditures, and rapid urbanization. The ongoing innovation and development of consumer-friendly blood testing products are expected to drive the blood testing market in Asia-Pacific.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Blood Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of autoimmune disorders among individuals and need for enhanced care
      • Government initiatives in blood testing checkup campaigns
      • Significant expansion of blood testing facilities worldwide
    • Market Restraints
      • Changing costs of raw materials and issues of product recalls
    • Market Opportunities
      • Rapid adoption of home-based healthcare and telemedicine
      • Advancements in blood testing products
    • Market Challenges
      • Inaccuracy in skin puncture and safety issues associated with blood testing products
  • Market Segmentation Analysis
    • Type: Significant penetration of basic metabolic panels for blood testing
    • Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
    • End-User: Emerging penetration of blood testing products in home care settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support

Quest Diagnostics expanded its health service offerings by including a new blood biomarker test, P-Tau217, aimed at enhancing the evaluation of Alzheimer's disease risk and aiding in its diagnosis. With the integration of P-Tau217 Blood Biomarker into their services, Quest Diagnostics provides critical insights into Alzheimer's disease. This development reflects Quest Diagnostics' commitment to advancing neurological health through innovative diagnostic solutions. [Published On: 2024-04-22]

Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service

Babson Diagnostics, a healthcare technology company, announced the launch of a new blood testing service. This new service aims to make blood testing more accessible and convenient by integrating it within retail environments, thus allowing consumers to undergo testing while they shop. The initiative promises to enhance the customer experience by drastically reducing the blood needed for testing and shortening the turnaround time for results, leveraging advanced diagnostic technologies and a network of state-of-the-art labs. [Published On: 2024-03-21]

Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics

Japan-based pharmaceutical company Eisai Co. has embarked on a strategic investment in C2N Diagnostics, a U.S. biotechnology that provides blood tests for Alzheimer's disease. This partnership aims to enhance the development and global distribution of C2N Diagnostics' innovative blood testing technology, which promises a less invasive, more accessible means of diagnosing Alzheimer's early. Eisai's investment aligns with its focus on neurological diseases and adds to its portfolio of treatments and diagnostics for Alzheimer's. [Published On: 2024-03-07]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents & kits
    • Software
  • Test Type
    • Basic Metabolic Panels
    • Complete Blood Count Tests
    • Complete Metabolic Panels
    • Electrolyte Panels
  • Application
    • Allergies
    • Autoimmune Diseases
    • Cancer/Noncancerous Blood Disorders
    • Endocrine System Disorders
    • Heart Diseases
  • End-User
    • Blood Banks
    • Diagnostic Centers
    • Hospital & Clinics
    • Pathology Labs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
      • 5.1.1.2. Government initiatives in blood testing checkup campaigns
      • 5.1.1.3. Significant expansion of blood testing facilities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Changing costs of raw materials and issues of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
      • 5.1.3.2. Advancements in blood testing products
    • 5.1.4. Challenges
      • 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
    • 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
    • 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & kits
  • 6.4. Software

7. Blood Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Basic Metabolic Panels
  • 7.3. Complete Blood Count Tests
  • 7.4. Complete Metabolic Panels
  • 7.5. Electrolyte Panels

8. Blood Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Allergies
  • 8.3. Autoimmune Diseases
  • 8.4. Cancer/Noncancerous Blood Disorders
  • 8.5. Endocrine System Disorders
  • 8.6. Heart Diseases

9. Blood Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Diagnostic Centers
  • 9.4. Hospital & Clinics
  • 9.5. Pathology Labs

10. Americas Blood Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
    • 13.3.2. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
    • 13.3.3. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 366. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 374. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 375. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 376. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 377. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 378. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 379. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 380. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2